Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

The benefits of measuring time in range, plus new care guidelines for adults with type 2 diabetes
Effective tips for surviving food-focused gatherings, defeating stress, cooking smart, sneaking in exercise, and optimizing sleep. Plus, clever recipes and great book...
The latest updates on time-in-range goals for people with all types of diabetes, and insights linking FreeStyle Libre scanning frequency to outcomes.
Resource at DANAtech.org for AADE members with current diabetes device information, news, education, and app reviews; supported by the Helmsley Charitable Trust
CGM accuracy, meal timing, n ew partnerships in diabetes tech, vitamin D for prediabetes, and more!
How we talk about diabetes matters; using empowering, non-stigmatizing words is important when speaking with and about people with diabetes
Learn more about JDRF’s efforts in finding a cure for type 1 diabetes and read highlights from experts’ discussions on SGLT inhibitors in type 1 and Beyond A1C
The VALyou program, designed to help people paying full-price for insulin not eligible for other patient assistance programs, now includes basal insulin Toujeo and rapid...
The latest on the first automated insulin delivery system with automatic boluses and no-fingersticks CGM. The pivotal trial has been temporarily paused and will resume...
Data on type 2 diabetes therapies and prevention, Medtronic MiniMed 780G trial starts, Beta Bionics Gen 3 iLet time-in-range results, and more!
Zealand Pharma shared positive trial results for its dasiglucagon – 99% of participants recovered from hypo within 15 minutes of treatment
Foot and hand cream, moisturizing cream, and cleansing wash now available at Walgreens, Target, and Amazon.com
Our readers have spoken! See ten of the most popular diaTribe articles.
Sanofi covers all insulins under this program, including Toujeo, Lantus, Admelog, Apidra.
By Peter Rentzepis and Kelly Close Passing of Dr. Lois Jovanovic, the leading figure in pregnancy and diabetes, brings sorrow to many; friends and colleagues share...
First drug trial to show delay in type 1 diagnoses, heart and kidney benefits from Trulicity in type 2, huge focus on time-in-range, positive results for both Tandem’s...
Why it’s a big deal for the closed loop and pump fields, when it might be available, and how Tidepool is working with the FDA and companies to make it happen
Transitioning care from parent to child can be a stressful time for families with diabetes – six strategies on how to reduce the burden
Google’s health arm Verily/Alcon has announced that its project to develop a glucose-sensing contact lens has been put on hold
A huge milestone that makes Forxiga the first pill for people with type 1 diabetes in Europe

Pages